Did you miss Cancer Research Week @ QIAGEN? Watch the recordings!

QIAcancerWeek_700x233_v2_02

Next-generation sequencing (NGS) is changing the face of cancer research and propelling us faster than ever toward smart, personalized solutions for attacking tumors. Recently we presented Cancer Research Week, a 4-part webinar series covering the latest advances in NGS to help you in your mission to reveal cancer’s secrets, from molecular barcodes to single cell sequencing.

Did you miss it? No need to worry; we’re now offering all 4 of these webinars on demand! Check out the abstracts here, and click on each of the titles below to stream the video.

Part I: Introduction to Unique Molecular Index (UMI) technology for targeted sequencing

Part II: Targeted DNA-seq for cancer mutation detection

Part III: miRNA-seq from liquid biopsy: robust detection from the lowest sample amounts

Part IV: Next-generation sequencing in single-cell applications

Thanks for attending, and for all you do to move cancer research forward. We hope you enjoy the webinars!

Ali Bierly

Ali Bierly, PhD is a Global Market Manager in Translational Sciences at QIAGEN, and has written on a number of scientific topics in the biotech industry as the author of QIAGEN's Reviews Online. She received her PhD from Cornell University in 2009, studying the immune response to a protozoan parasite, Toxoplasma gondii. Ali has a keen interest in the emerging importance of microRNA and other circulating nucleic acids as biomarkers for disease.

Your email address will not be published. Required fields are marked *